Literature DB >> 24922466

Usage of benzodiazepines: A review.

John Donoghue1, Malcolm Lader.   

Abstract

Abstract Purpose. The use of benzodiazepines remains a source of controversy. Some prescribers believe that they are beneficial and espouse their use; others regard their risk:benefit ratio as too adverse for any but occasional use. This review considers these viewpoints based on the appropriate literature. Survey. The recent English-language literature relating to this topic was surveyed. The publications proved too heterogeneous for a formal meta-analysis, so a descriptive review is provided. Overview. Surveys of benzodiazepine use provide data mainly from the UK, Europe and North America. Prescribing patterns varied widely but long-term usage is common and sometimes the norm. Conclusions. Long-term prescription of benzodiazepines still takes place despite general warnings from the medical and other professions and drug regulatory bodies that long-term use is unjustified both from the lack of a systemic database establishing such efficacy and a large literature documenting the risks of long-term usage, such as dependence. The young and the old are particularly at risk. Continued monitoring is essential, but the regulatory authorities may need to take a more active role in curbing such undesirable practice.

Entities:  

Keywords:  Benzodiazepines; dependence problems; long-term usage; prescriptions

Year:  2010        PMID: 24922466     DOI: 10.3109/13651500903447810

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  45 in total

Review 1.  Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Authors:  Brendan J Ng; David G Le Couteur; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

2.  Long-term sedative use among community-dwelling adults: a population-based analysis.

Authors:  Deirdre Weymann; Emilie J Gladstone; Kate Smolina; Steven G Morgan
Journal:  CMAJ Open       Date:  2017-03-03

Review 3.  The Benzodiazepine-Dementia Disorders Link: Current State of Knowledge.

Authors:  Antoine Pariente; Sophie Billioti de Gage; Nicholas Moore; Bernard Bégaud
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

4.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

5.  Changes in Australian Early-Career General Practitioners' Benzodiazepine Prescribing: a Longitudinal Analysis.

Authors:  Parker Magin; Amanda Tapley; Adrian J Dunlop; Andrew Davey; Mieke van Driel; Elizabeth Holliday; Simon Morgan; Kim Henderson; Jean Ball; Nigel Catzikiris; Katie Mulquiney; Neil Spike; Rohan Kerr; Simon Holliday
Journal:  J Gen Intern Med       Date:  2018-07-23       Impact factor: 5.128

6.  Prevalence of and Factors Related to Prescription Opioids, Benzodiazepines, and Hypnotics Among Medicare Home Health Recipients.

Authors:  Brandi P Cotton; Matthew C Lohman; Jessica M Brooks; Karen L Whiteman; Yuhua Bao; Rebecca L Greenberg; Martha L Bruce
Journal:  Home Healthc Now       Date:  2017-06

7.  Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada.

Authors:  Steven G Morgan; Deirdre Weymann
Journal:  Eur J Clin Pharmacol       Date:  2017-04-24       Impact factor: 2.953

Review 8.  Benzodiazepine harm: how can it be reduced?

Authors:  Malcolm Lader
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 9.  Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

Authors:  Malcolm Lader; Andri Kyriacou
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

10.  Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015.

Authors:  Cathal A Cadogan; Cristín Ryan; Caitriona Cahir; Colin P Bradley; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.